Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APLD NASDAQ:ARM NASDAQ:CRWV NASDAQ:NBIS NASDAQ:NVDA NASDAQ:RXRX NASDAQ:WRD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPLDApplied Digital$9.49-0.2%$8.88$3.01▼$15.42$2.14B6.0438.77 million shs11.99 million shsARMARM$147.62-0.3%$137.39$80.00▼$187.47$156.26B4.196.11 million shs2.19 million shsCRWVCoreWeave$145.80-4.7%$123.13$33.51▼$187.00$69.98BN/A20.50 million shs8.13 million shsNBISNebius Group$46.79+1.6%$41.93$14.09▼$55.75$11.03B3.2511.22 million shs6.84 million shsNVDANVIDIA$164.09+0.7%$139.47$86.62▼$164.70$4.01T2.13266.45 million shs114.54 million shsRXRXRecursion Pharmaceuticals$5.64+0.8%$4.82$3.79▼$12.36$2.30B0.9116.42 million shs21.52 million shsWRDWeRide$8.90+3.9%$8.62$6.03▼$44.00$2.37BN/A7.77 million shs5.67 million shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPLDApplied Digital+3.15%-9.94%-26.96%+85.38%+73.86%ARMARM+0.16%-4.27%+6.79%+47.34%-18.80%CRWVCoreWeave+1.06%+0.84%-5.58%+262.68%+15,304,999,900.00%NBISNebius Group-2.23%-7.84%-12.42%+118.87%+4,604,999,900.00%NVDANVIDIA+1.80%+3.58%+14.20%+51.42%+23.98%RXRXRecursion Pharmaceuticals+4.29%+7.29%+4.10%+23.95%-24.87%WRDWeRide+0.12%+6.86%-6.34%-12.64%+856,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAPLDApplied Digital3.6398 of 5 stars4.52.00.00.02.03.30.6ARMARM2.1253 of 5 stars2.33.00.00.02.80.01.9CRWVCoreWeaveN/AN/AN/AN/AN/AN/AN/AN/ANBISNebius Group3.3162 of 5 stars4.70.00.00.03.40.00.6NVDANVIDIA4.7221 of 5 stars2.55.01.73.03.42.51.9RXRXRecursion Pharmaceuticals1.1716 of 5 stars2.21.00.00.02.61.70.6WRDWeRideN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPLDApplied Digital 3.00Buy$12.7334.11% UpsideARMARM 2.64Moderate Buy$154.004.32% UpsideCRWVCoreWeave 2.13Hold$74.59-48.84% DownsideNBISNebius Group 3.33Buy$66.5042.12% UpsideNVDANVIDIA 2.93Moderate Buy$177.037.88% UpsideRXRXRecursion Pharmaceuticals 2.33Hold$7.0024.22% UpsideWRDWeRide 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest NVDA, CRWV, ARM, APLD, NBIS, WRD, and RXRX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/10/2025ARMARMThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$160.007/10/2025CRWVCoreWeaveNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold$78.007/10/2025NVDANVIDIAThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$185.007/8/2025CRWVCoreWeaveStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy ➝ Hold$75.00 ➝ $115.007/8/2025CRWVCoreWeaveMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Neutral$70.00 ➝ $150.007/8/2025RXRXRecursion PharmaceuticalsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$8.007/7/2025NVDANVIDIACitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$180.00 ➝ $190.007/3/2025ARMARMMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$160.00 ➝ $180.007/3/2025NVDANVIDIAMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$170.00 ➝ $185.007/3/2025RXRXRecursion PharmaceuticalsMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageEqual Weight$5.006/30/2025ARMARMGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$147.00 ➝ $187.00(Data available from 7/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPLDApplied Digital$221.19M9.66N/AN/A$0.91 per share10.43ARMARM$4.01B39.02$1.25 per share117.93$6.53 per share22.61CRWVCoreWeaveN/AN/AN/AN/AN/AN/ANBISNebius Group$117.50M93.88N/AN/A$13.80 per share3.39NVDANVIDIA$148.52B26.96$3.14 per share52.33$3.25 per share50.49RXRXRecursion Pharmaceuticals$58.84M38.93N/AN/A$2.61 per share2.16WRDWeRide$49.47M47.90N/AN/A$3.84 per share2.32Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPLDApplied Digital-$149.27M-$1.37N/AN/AN/A-109.99%-77.49%-19.66%7/24/2025 (Estimated)ARMARM$792M$0.75196.69127.266.7919.76%17.97%13.42%7/30/2025 (Estimated)CRWVCoreWeaveN/AN/A0.00∞N/AN/AN/AN/AN/ANBISNebius Group-$641.40M-$0.57N/AN/AN/AN/A-10.24%-9.69%7/29/2025 (Estimated)NVDANVIDIA$72.88B$3.1053.0341.231.4251.69%105.09%72.19%8/27/2025 (Estimated)RXRXRecursion Pharmaceuticals-$463.66M-$1.77N/AN/AN/A-961.32%-74.70%-54.02%8/6/2025 (Estimated)WRDWeRide-$350.09MN/A0.00N/AN/AN/AN/AN/AN/ALatest NVDA, CRWV, ARM, APLD, NBIS, WRD, and RXRX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2025Q1 2026ARMARM$0.34N/AN/AN/A$1.06 billionN/A7/29/2025Q2 2025NBISNebius Group-$0.41N/AN/AN/A$95.60 millionN/A5/28/2025Q1 2026NVDANVIDIA$0.87$0.81-$0.06$0.76$43.09 billion$44.06 billion5/21/2025Q1 2025WRDWeRideN/A-$0.18N/A-$0.18N/A$9.98 million5/14/2025Q1 2025CRWVCoreWeave-$0.16-$0.83-$0.67-$1.49N/AN/A5/7/2025Q4 2025ARMARM$0.52$0.55+$0.03$0.20$1.23 billion$1.24 billion5/5/2025Q1 2025RXRXRecursion Pharmaceuticals-$0.44-$0.50-$0.06-$0.50$18.12 million$14.75 million4/14/2025Q3 2025APLDApplied Digital-$0.11-$0.16-$0.05-$0.16$62.91 million$52.92 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPLDApplied DigitalN/AN/AN/AN/AN/AARMARMN/AN/AN/AN/AN/ACRWVCoreWeaveN/AN/AN/AN/AN/ANBISNebius GroupN/AN/AN/AN/AN/ANVDANVIDIA$0.040.02%N/A1.29%1 YearsRXRXRecursion PharmaceuticalsN/AN/AN/AN/AN/AWRDWeRideN/AN/AN/AN/AN/ALatest NVDA, CRWV, ARM, APLD, NBIS, WRD, and RXRX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/28/2025NVDANVIDIAquarterly$0.010.03%6/11/20256/11/20257/3/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPLDApplied Digital1.560.700.70ARMARMN/A5.205.20CRWVCoreWeave2.600.440.44NBISNebius GroupN/A18.0018.00NVDANVIDIA0.103.392.96RXRXRecursion Pharmaceuticals0.024.114.11WRDWeRide0.0113.6013.10Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPLDApplied Digital65.67%ARMARM7.53%CRWVCoreWeaveN/ANBISNebius Group21.90%NVDANVIDIA65.27%RXRXRecursion Pharmaceuticals89.06%WRDWeRideN/AInsider OwnershipCompanyInsider OwnershipAPLDApplied Digital11.81%ARMARMN/ACRWVCoreWeaveN/ANBISNebius GroupN/ANVDANVIDIA4.17%RXRXRecursion Pharmaceuticals8.43%WRDWeRide2.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPLDApplied Digital121225.07 million198.49 millionOptionableARMARM8,3301.06 billionN/ANot OptionableCRWVCoreWeave881479.98 millionN/AN/ANBISNebius Group1,371235.75 millionN/AN/ANVDANVIDIA36,00024.40 billion23.38 billionOptionableRXRXRecursion Pharmaceuticals400406.49 million372.23 millionOptionableWRDWeRide3,093266.26 million259.07 millionN/ANVDA, CRWV, ARM, APLD, NBIS, WRD, and RXRX HeadlinesRecent News About These CompaniesWRD - WeRide Inc ADR Dividends - MorningstarJuly 8 at 7:09 PM | morningstar.comMWeRide (NASDAQ:WRD) Downgraded to "Sell" Rating by Wall Street ZenJuly 5, 2025 | marketbeat.comWeRide secures landmark autonomous vehicle testing permit in Guangzhou (WRD:NASDAQ) - Seeking AlphaJuly 4, 2025 | seekingalpha.comWeRide stock rises after securing autonomous vehicle testing permit in GuangzhouJuly 3, 2025 | in.investing.comWeRide stock climbs 2% after securing autonomous vehicle testing permit in GuangzhouJuly 3, 2025 | msn.comWeRide secures landmark autonomous vehicle testing permit in GuangzhouJuly 3, 2025 | msn.comWeRide Secures First Driverless Logistics Vehicle Test Permit in Guangzhou's Huangpu District for Robovan W5July 2, 2025 | globenewswire.comMirae Asset Global Investments Co. Ltd. Purchases New Stake in WeRide Inc. (NASDAQ:WRD)June 30, 2025 | marketbeat.comUber Technologies rallies after Atlanta Waymo expansion, Tesla's stumbles in AustinJune 24, 2025 | msn.comWeRide (NASDAQ:WRD) Trading Up 9.2% - Should You Buy?June 24, 2025 | marketbeat.comWeRide Target of Unusually Large Options Trading (NASDAQ:WRD)June 24, 2025 | marketbeat.comWaymo applies for special permit to bring its self-driving cars to New York CityJune 18, 2025 | aol.comAWeRide Partners With Uber, Dubai's Road And Transport Authority For Autonomous Vehicle PilotJune 17, 2025 | benzinga.comWeRide Robotaxis To Start Operating In Dubai Via Uber This Year: Retail Sees Stock Breach $6 This WeekJune 17, 2025 | msn.comWeRide signs MoU with Dubai, Uber for pilot AV programJune 16, 2025 | msn.comWeRide (NASDAQ:WRD) Shares Gap Up - Still a Buy?June 16, 2025 | marketbeat.comTrial run of robo-taxis by year endJune 16, 2025 | gulftoday.aeGTimeline r: Dubai to start driverless cars trials with Uber, WeRideJune 15, 2025 | msn.comWeRide (NASDAQ:WRD) Upgraded to Hold at Wall Street ZenJune 15, 2025 | marketbeat.comHow Waymo got the edge on the competition and Tesla's robotaxi (so far)June 14, 2025 | aol.comAWeRide (NASDAQ:WRD) Trading Down 5.5% - Here's WhyJune 13, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesNVIDIA’s Stock Price Hits New Highs: This Is What’s NextBy Thomas Hughes | June 26, 2025View NVIDIA’s Stock Price Hits New Highs: This Is What’s NextWhy Nebius Group Is One of the Top AI Stocks to WatchBy Thomas Hughes | June 17, 2025View Why Nebius Group Is One of the Top AI Stocks to Watch3 Blockchain Stocks to Profit in a Decentralized WorldBy Chris Markoch | June 24, 2025View 3 Blockchain Stocks to Profit in a Decentralized WorldS&P 500 All-Time Highs: 5 Catalysts Driving It HigherBy Thomas Hughes | June 30, 2025View S&P 500 All-Time Highs: 5 Catalysts Driving It HigherTop 4 Growth Stocks With Momentum and Room to RunBy Ryan Hasson | June 16, 2025View Top 4 Growth Stocks With Momentum and Room to RunNVDA, CRWV, ARM, APLD, NBIS, WRD, and RXRX Company DescriptionsApplied Digital NASDAQ:APLD$9.49 -0.02 (-0.21%) As of 01:53 PM EasternApplied Digital Corporation designs, develops, and operates datacenters in North America. Its datacenters provide digital infrastructure solutions to the high-performance computing industry. The company also provides artificial intelligence cloud services, high performance computing datacenter hosting, and crypto datacenter hosting services. The company was formerly known as Applied Blockchain, Inc. and changed its name to Applied Digital Corporation in November 2022. Applied Digital Corporation is based in Dallas, Texas.ARM NASDAQ:ARM$147.62 -0.40 (-0.27%) As of 02:16 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.CoreWeave NASDAQ:CRWV$145.80 -7.25 (-4.74%) As of 01:54 PM EasternCoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.Nebius Group NASDAQ:NBIS$46.79 +0.74 (+1.61%) As of 02:17 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Nebius Group N.V., a technology company, builds intelligent products and services powered by machine learning and other technologies to help consumers and businesses navigate the online and offline world. The company's services include Nebius AI, an AI-centric cloud platform that offers infrastructure and computing capability for AI deployment and machine-learning oriented solutions; and Toloka AI that offers generative AI (GenAI) solutions at every stage of the GenAI lifecycle, such as data annotation and generation, model training and fine-tuning, and quality assessment of large language model for accuracy and reliability. It also offers Avride, an autonomous driving solution which targets ride-hailing, logistics, e-commerce, and food/grocery delivery as application domains, as well as focuses on autonomous vehicles and delivery robots; and TripleTen, an EdTech service that prepares specialists for STEM roles, and equipping them with essential technology skills. The company was formerly known as Yandex N.V. and changed its name to Nebius Group N.V. in August 2024. Nebius Group N.V. was founded in 1989 and is based in Schiphol, the Netherlands.NVIDIA NASDAQ:NVDA$164.09 +1.21 (+0.74%) As of 02:17 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.Recursion Pharmaceuticals NASDAQ:RXRX$5.64 +0.05 (+0.81%) As of 02:16 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.WeRide NASDAQ:WRD$8.90 +0.33 (+3.85%) As of 01:54 PM EasternWeRide, Inc. engages in the development of an autonomous driving technology platform. It offers Robotaxi, Robobus, Robovan, Robosweeper, and advanced driving solutions, providing smart services in online ride-hailing, on-demand transport, urban logistics, and environmental sanitation. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Will Oracle's Cloud and AI Deals Propel It to New Highs? Enovix Shares Hit 6-Month High; Long-Term Highs to Follow Tesla Stock Could Accelerate on New EV Tax Legislation SoundHound Rises as Short Sellers Exit and AI Demand Grows Why Microsoft Keeps Showing Up in Congressional Portfolios Buffett's $2B+ Bet With Big Long-Term Potential Just Got Upgraded Why Marvell Could Be the Smartest AI Bet Under $80 Autodesk Stock Ready to Rip? Q3 May Be the Turning Point Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
